AEON Biopharma, Inc. (NYSE American: AEON) announced it has received official minutes from a Biosimilar Biological Product Development Type 2b ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE